CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomasJoseph Flores‐Toro, Jeffrey K. Harrison, Meenal Datta et al.|Proceedings of the National Academy of Sciences|2019Cited by 330